The primary objective of this proposal is to continue our longstanding cardiopulmonary research training efforts at the University of Colorado Anschutz Medical Campus (CUAMC). This program trains individuals with doctoral degrees in either biological or medical sciences for successful academic careers. A multidisciplinary team oriented approach to both mentoring and research training is emphasizing the integration of studies at the molecular, cellular, tissue organ, and physiological (whole animals or human subjects) levels to permit rapid bench-to-bedside translation of the work performed. We have continued to expand the focus of the training program to include access to expertise in Bioengineering, Biomaterials, Regenerative Medicine, Genomics and Metabolomics and Redox Biology. This expanded focus will enable us to involve outstanding programs and investigators whose work is directly related to cardiopulmonary biology. Of the many training grants at CUAMC, this is the only one specifically dedicated to pulmonary vascular biology. Our continuing and long-term goal is that after 3 years of training the program's fellows will have acquired the professional skills to be competitive for research and/or teaching positions and obtain their own extramural funds. Our records show that we have achieved this benchmark. Our specific objectives are: 1) To attract and select talented and highly motivated fellows who have a demonstrated interest in cardiovascular and pulmonary diseases. 2) To provide trainee fellows with an intensive research experience in cardiovascular-pulmonary research with a focus on the pathophysiological aspects of chronic pulmonary vascular disease and right heart failure, by pairing them with mentors who are rigorously selected based on their qualifications and scientific area of expertise and placing them in a collaborative, stimulating environment. 3) To enhance the scientific knowledge and critical thinking abilities of the participating trainees by requiring a series of workshops/lectures on hypothesis formulation, experimental design, reporting and presentation of scientific information, grant proposal preparation and hands on experience in innovative molecular and cellular physiological approaches to cardiovascular-pulmonary research. 4) To enhance multidisciplinary, collaborative approaches to research by requiring co-mentors and a Team-oriented T-shaped Development for T-32 Trainees (T4) approach along with strong interaction with Advisory Committees. 5) To ensure that Fellows acquire the necessary information to conduct research in an ethical manner. 6) To help the trainees/scientists develop proficiency with a wide array of non-bench professional skills necessary for biomedical research careers such as communication, leadership development, and project management and professionalism. The increasing national and international interest in pulmonary vascular biology, the expanded nature of our program, and the excellent track record of training individuals from all backgrounds, including underrepresented minorities, support our request for 6 postdoctoral trainees each year.
A large number of human diseases can affect the structure and function of blood vessels in the lung. In fact, when diseases are complicated by increases in pressure in the lung blood vessels (lung vascular disease), significant increases in morbidity and mortality are observed, which are often due to dysfunction or failure of the right heart. This program is directed at training individuals to better understand the causes of lung vascular and right heart disease with the long-tem goal that these investigators will develop new therapies to decrease or ameliorate the health burden of lung vascular problems.
|Tomko, Lucas A; Hill, Ryan C; Barrett, Alexander et al. (2018) Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma. Sci Rep 8:12941|
|Chicco, Adam J; Le, Catherine H; Gnaiger, Erich et al. (2018) Adaptive remodeling of skeletal muscle energy metabolism in high-altitude hypoxia: Lessons from AltitudeOmics. J Biol Chem 293:6659-6671|
|Keller, A C; Knaub, L A; Scalzo, R L et al. (2018) Sepiapterin Improves Vascular Reactivity and Insulin-Stimulated Glucose in Wistar Rats. Oxid Med Cell Longev 2018:7363485|
|Graham, Brian B; Kumar, Rahul; Mickael, Claudia et al. (2018) Vascular Adaptation of the Right Ventricle in Experimental Pulmonary Hypertension. Am J Respir Cell Mol Biol 59:479-489|
|Almodovar, Sharilyn; Swanson, Jessica; Giavedoni, Luis D et al. (2018) Lung Vascular Remodeling, Cardiac Hypertrophy, and Inflammatory Cytokines in SHIVnef-Infected Macaques. Viral Immunol 31:206-222|
|Reisz, Julie A; Barrett, Alexander S; Nemkov, Travis et al. (2018) When nature's robots go rogue: exploring protein homeostasis dysfunction and the implications for understanding human aging disease pathologies. Expert Rev Proteomics 15:293-309|
|Ferguson, Scott K; Harral, Julie W; Pak, David I et al. (2018) Impact of cell-free hemoglobin on contracting skeletal muscle microvascular oxygen pressure dynamics. Nitric Oxide 76:29-36|
|Wahl, Matthew P; Scalzo, Rebecca L; Regensteiner, Judith G et al. (2018) Mechanisms of Aerobic Exercise Impairment in Diabetes: A Narrative Review. Front Endocrinol (Lausanne) 9:181|
|Zhang, Hui; Wang, Daren; Li, Min et al. (2017) Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis. Circulation 136:2468-2485|
|Kumar, Rahul; Mickael, Claudia; Kassa, Biruk et al. (2017) TGF-? activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension. Nat Commun 8:15494|
Showing the most recent 10 out of 128 publications